Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders??? Equity

v3.21.1
Consolidated Statement of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 4 $ 195,666 $ (186,857) $ 8,813
Balance (in Shares) at Dec. 31, 2018 3,856,768      
Stock-based compensation 1,295 1,295
Stock-based compensation (in Shares) 13,143      
Sale of common stock and warrants, net of offering costs $ 1 15,931 15,932
Sale of common stock and warrants, net of offering costs (in Shares) 1,535,334      
Issuance of common stock from exercise of warrants 1,504 1,504
Issuance of common stock from exercise of warrants (in Shares) 84,793      
Deemed dividend for warrant down-round protection provision 1 (1)
Net loss (21,900) (21,900)
Balance, at Dec. 31, 2019 $ 5 214,397 (208,758) 5,644
Balance, (in Shares) at Dec. 31, 2019 5,490,038      
Stock-based compensation 1,254 1,254
Stock-based compensation (in Shares) 6,262      
Sale of common stock and warrants, net of offering costs $ 9 76,580 76,589
Sale of common stock and warrants, net of offering costs (in Shares) 8,575,051      
Issuance of common stock from exercise of pre-funded warrants $ 4 6 10
Issuance of common stock from exercise of pre-funded warrants (in Shares) 3,458,929      
Issuance of common stock from exercise of warrants 37 37
Issuance of common stock from exercise of warrants (in Shares) 2,613      
Deemed dividend for warrant down-round protection provision 1 (1)
Net loss (22,215) (22,215)
Balance, at Dec. 31, 2020 $ 18 $ 292,275 $ (230,974) $ 61,319
Balance, (in Shares) at Dec. 31, 2020 17,532,893